X-41542815-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001367721.1(CASK):​c.2040-9A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00124 in 1,019,577 control chromosomes in the GnomAD database, including 11 homozygotes. There are 310 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0056 ( 5 hom., 156 hem., cov: 23)
Exomes 𝑓: 0.00070 ( 6 hom. 154 hem. )

Consequence

CASK
NM_001367721.1 intron

Scores

2
Splicing: ADA: 0.00002441
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.30

Publications

0 publications found
Variant links:
Genes affected
CASK (HGNC:1497): (calcium/calmodulin dependent serine protein kinase) This gene encodes a calcium/calmodulin-dependent serine protein kinase. The encoded protein is a MAGUK (membrane-associated guanylate kinase) protein family member. These proteins are scaffold proteins and the encoded protein is located at synapses in the brain. Mutations in this gene are associated with FG syndrome 4, intellectual disability and microcephaly with pontine and cerebellar hypoplasia, and a form of X-linked intellectual disability. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
CASK Gene-Disease associations (from GenCC):
  • FG syndrome 4
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • syndromic X-linked intellectual disability Najm type
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • X-linked syndromic intellectual disability
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant X-41542815-T-C is Benign according to our data. Variant chrX-41542815-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 158068.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00556 (623/111980) while in subpopulation AFR AF = 0.0192 (594/30882). AF 95% confidence interval is 0.018. There are 5 homozygotes in GnomAd4. There are 156 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High AC in GnomAd4 at 623 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CASKNM_001367721.1 linkc.2040-9A>G intron_variant Intron 21 of 26 ENST00000378163.7 NP_001354650.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CASKENST00000378163.7 linkc.2040-9A>G intron_variant Intron 21 of 26 5 NM_001367721.1 ENSP00000367405.1 O14936-1

Frequencies

GnomAD3 genomes
AF:
0.00553
AC:
619
AN:
111925
Hom.:
5
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0191
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000373
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0169
Gnomad NFE
AF:
0.0000564
Gnomad OTH
AF:
0.00596
GnomAD2 exomes
AF:
0.00159
AC:
282
AN:
176894
AF XY:
0.000950
show subpopulations
Gnomad AFR exome
AF:
0.0208
Gnomad AMR exome
AF:
0.000417
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000704
AC:
639
AN:
907597
Hom.:
6
Cov.:
18
AF XY:
0.000639
AC XY:
154
AN XY:
241015
show subpopulations
African (AFR)
AF:
0.0223
AC:
510
AN:
22900
American (AMR)
AF:
0.000553
AC:
19
AN:
34351
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18046
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29349
South Asian (SAS)
AF:
0.0000828
AC:
4
AN:
48303
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39804
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3717
European-Non Finnish (NFE)
AF:
0.0000223
AC:
15
AN:
671318
Other (OTH)
AF:
0.00229
AC:
91
AN:
39809
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
21
43
64
86
107
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00556
AC:
623
AN:
111980
Hom.:
5
Cov.:
23
AF XY:
0.00457
AC XY:
156
AN XY:
34170
show subpopulations
African (AFR)
AF:
0.0192
AC:
594
AN:
30882
American (AMR)
AF:
0.00124
AC:
13
AN:
10518
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2657
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3600
South Asian (SAS)
AF:
0.000374
AC:
1
AN:
2675
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6024
Middle Eastern (MID)
AF:
0.0139
AC:
3
AN:
216
European-Non Finnish (NFE)
AF:
0.0000564
AC:
3
AN:
53191
Other (OTH)
AF:
0.00588
AC:
9
AN:
1530
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
23
46
69
92
115
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00243
Hom.:
9
Bravo
AF:
0.00640

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Apr 14, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 21, 2014
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 22, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Intellectual disability, CASK-related, X-linked Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
1.7
DANN
Benign
0.54
PhyloP100
-1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000024
dbscSNV1_RF
Benign
0.014
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138290714; hg19: chrX-41402068; API